A 66-year-old with COPD has ≥2 exacerbations in the past year and blood eosinophils 420/µL. Post-bronchodilator FEV₁ is 48% predicted. Which inhaled r...

Question

A 66-year-old with COPD has ≥2 exacerbations in the past year and blood eosinophils 420/µL. Post-bronchodilator FEV₁ is 48% predicted. Which inhaled regimen is preferred to reduce future exacerbations?

Accepted Answer

LABA/LAMA/ICS triple therapy

Answer

Short-acting beta-agonist as needed only

Answer

LAMA monotherapy

Answer

LABA monotherapy

Answer

LABA/LAMA dual bronchodilator

us-abfm MCQ (SBA): COPD Pharmacotherapy

A 66-year-old with COPD has ≥2 exacerbations in the past year and blood eosinophils 420/µL. Post-bronchodilator FEV₁ is 48% predicted. Which inhaled regimen is preferred to reduce future exacerbations?